278 related articles for article (PubMed ID: 36001650)
1. The global burden of disease attributable to high fasting plasma glucose in 204 countries and territories, 1990-2019: An updated analysis for the Global Burden of Disease Study 2019.
Liang R; Feng X; Shi D; Yang M; Yu L; Liu W; Zhou M; Wang X; Qiu W; Fan L; Wang B; Chen W
Diabetes Metab Res Rev; 2022 Nov; 38(8):e3572. PubMed ID: 36001650
[TBL] [Abstract][Full Text] [Related]
2. Global, regional, and national burden of chronic kidney disease attributable to high fasting plasma glucose from 1990 to 2019: a systematic analysis from the global burden of disease study 2019.
Wei H; Ren J; Li R; Qi X; Yang F; Li Q
Front Endocrinol (Lausanne); 2024; 15():1379634. PubMed ID: 38601204
[TBL] [Abstract][Full Text] [Related]
3. Global disease burden of stroke attributable to high fasting plasma glucose in 204 countries and territories from 1990 to 2019: An analysis of the Global Burden of Disease Study.
Liu Y; Wang W; Huang X; Zhang X; Lin L; Qin JJ; Lei F; Cai J; Cheng B
J Diabetes; 2022 Aug; 14(8):495-513. PubMed ID: 35924673
[TBL] [Abstract][Full Text] [Related]
4. Global, Regional and National Burden of Cancers Attributable to High Fasting Plasma Glucose in 204 Countries and Territories, 1990-2019.
Safiri S; Nejadghaderi SA; Karamzad N; Kaufman JS; Carson-Chahhoud K; Bragazzi NL; Sullman MJM; Beyranvand MR; Mansournia MA; Almasi-Hashiani A; Collins GS; Kolahi AA
Front Endocrinol (Lausanne); 2022; 13():879890. PubMed ID: 35966097
[TBL] [Abstract][Full Text] [Related]
5. Burden of cancers attributable to high fasting plasma glucose in the Middle East and North Africa region, 1990-2019.
Tondro Anamag F; Noori M; Nejadghaderi SA; Sullman MJM; Grieger JA; Kolahi AA; Safiri S
Cancer Med; 2023 Apr; 12(8):10031-10044. PubMed ID: 36951550
[TBL] [Abstract][Full Text] [Related]
6. Global burden of MDR-TB and XDR-TB attributable to high fasting plasma glucose from 1990 to 2019: a retrospective analysis based on the global burden of disease study 2019.
Chen Y; Liu J; Zhang Q; Chen H; Chai L; Wang Y; Zhang J; Qiu Y; Shen N; Shi X; Wang Q; Wang J; Li S; Li M
Eur J Clin Microbiol Infect Dis; 2024 Apr; 43(4):747-765. PubMed ID: 38367094
[TBL] [Abstract][Full Text] [Related]
7. Global, regional, and national burden of blindness and vision loss attributable to high fasting plasma glucose from 1990 to 2019, and forecasts to 2030: A systematic analysis for the Global Burden of Disease Study 2019.
Li C; Hua G; Liu S; Yu H; Yang X; Liu L
Diabetes Metab Res Rev; 2024 May; 40(4):e3802. PubMed ID: 38634501
[TBL] [Abstract][Full Text] [Related]
8. The burden of cardiovascular disease attributable to high fasting plasma glucose：Findings from the global burden of disease study 2019.
Dong XJ; Zhang XQ; Wang BB; Hou FF; Jiao Y
Diabetes Metab Syndr; 2024 May; 18(5):103025. PubMed ID: 38851022
[TBL] [Abstract][Full Text] [Related]
9. Global and regional estimates of tuberculosis burden attributed to high fasting plasma glucose from 1990 to 2019: emphasis on earlier glycemic control.
Bian Q; Zhang Y; Xue C; Lu W; Li W; Pan F; Li Y
BMC Public Health; 2024 Mar; 24(1):782. PubMed ID: 38481192
[TBL] [Abstract][Full Text] [Related]
10. Burden of type 1 and type 2 diabetes and high fasting plasma glucose in Europe, 1990-2019: a comprehensive analysis from the global burden of disease study 2019.
Liang D; Cai X; Guan Q; Ou Y; Zheng X; Lin X
Front Endocrinol (Lausanne); 2023; 14():1307432. PubMed ID: 38152139
[TBL] [Abstract][Full Text] [Related]
11. The global burden of disease attributable to high body mass index in 195 countries and territories, 1990-2017: An analysis of the Global Burden of Disease Study.
Dai H; Alsalhe TA; Chalghaf N; Riccò M; Bragazzi NL; Wu J
PLoS Med; 2020 Jul; 17(7):e1003198. PubMed ID: 32722671
[TBL] [Abstract][Full Text] [Related]
12. Estimates and trends of the global burden of NASH-related liver cancer attributable to high fasting plasma glucose in 1990-2019: analysis of data from the 2019 Global Burden of Disease Study.
Li Z; Yang N; He L; Wang J; Ping F; Li W; Xu L; Zhang H; Li Y
Diabetol Metab Syndr; 2023 Jan; 15(1):6. PubMed ID: 36647090
[TBL] [Abstract][Full Text] [Related]
13. Global burden of noncommunicable diseases attributable to high fasting plasma glucose.
Ye L; Xu J; Zhang T; Lin X; Pan X; Zeng W; Ren Y; Shan P
J Diabetes; 2020 Nov; 12(11):807-818. PubMed ID: 32472661
[TBL] [Abstract][Full Text] [Related]
14. The global burden of disease attributable to ambient fine particulate matter in 204 countries and territories, 1990-2019: A systematic analysis of the Global Burden of Disease Study 2019.
Sang S; Chu C; Zhang T; Chen H; Yang X
Ecotoxicol Environ Saf; 2022 Jun; 238():113588. PubMed ID: 35525115
[TBL] [Abstract][Full Text] [Related]
15. Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the Global Burden of Disease Study 2017.
Li N; Deng Y; Zhou L; Tian T; Yang S; Wu Y; Zheng Y; Zhai Z; Hao Q; Song D; Zhang D; Kang H; Dai Z
J Hematol Oncol; 2019 Dec; 12(1):140. PubMed ID: 31864424
[TBL] [Abstract][Full Text] [Related]
16. Global, regional, and national burden of tracheal, bronchus, and lung cancers attributable to high fasting plasma glucose: A systematic analysis of global burden of disease 2019.
Wang M; Liu J; Wang J; Jin Y; Zheng ZJ
J Diabetes; 2024 Mar; 16(3):e13499. PubMed ID: 38009553
[TBL] [Abstract][Full Text] [Related]
17. Temporal trend and global burden of type 2 diabetes attributable to non-optimal temperature, 1990-2019: an analysis for the Global Burden of Disease Study 2019.
Liu Y; Wang D; Huang X; Liang R; Tu Z; You X; Zhou M; Chen W
Environ Sci Pollut Res Int; 2023 Jul; 30(34):82686-82695. PubMed ID: 37328723
[TBL] [Abstract][Full Text] [Related]
18. Global, regional, and national trends in osteoarthritis disability-adjusted life years (DALYs) from 1990 to 2019: a comprehensive analysis of the global burden of disease study.
Ding Y; Liu X; Chen C; Yin C; Sun X
Public Health; 2024 Jan; 226():261-272. PubMed ID: 38134839
[TBL] [Abstract][Full Text] [Related]
19. Global, regional, and national time trends in cancer mortality attributable to high fasting plasma glucose: an age-period cohort analysis.
Xie J; Liu Z; Ren L; He L; Lu S; Meng X; Zhang X; Su Z; Jing S; Shan T; Wang J; Xia R; Feng W; Li Y; Liu N; Liu Y
BMC Public Health; 2023 Jul; 23(1):1361. PubMed ID: 37454041
[TBL] [Abstract][Full Text] [Related]
20. Temporal trends in mortality of tuberculosis attributable to high fasting plasma glucose in China from 1990 to 2019: a joinpoint regression and age-period-cohort analysis.
Wang C; Yang X; Zhang H; Zhang Y; Tao J; Jiang X; Wu C
Front Public Health; 2023; 11():1225931. PubMed ID: 37575123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
